HOME >> BIOLOGY >> NEWS
Novel bacterium detoxifies chlorinated pollutants

Researchers have isolated a novel bacterium that flourishes as it destroys harmful chlorinated compounds in polluted environments, leaving behind environmentally benign end products. The finding opens the door for designing more efficient and successful bioremediation strategies for thousands of contaminated sites that remain threats, despite years of expensive cleanup work.

"This organism might be useful for cleaning contaminated subsurface environments and restoring drinking-water reservoirs," Georgia Institute of Technology researchers report in the July 3, 2003 issue of the journal Nature.

The paper, titled "Detoxification of vinyl chloride to ethene coupled to growth of an anaerobic bacterium" is the culmination of five years of field and laboratory studies funded by the National Science Foundation and the Strategic Environmental Research and Development Program.

Scientists and engineers have struggled for years with clean up of groundwater and subsurface environments contaminated decades ago by unregulated use of the common solvents tetrachloroethene (PCE) and trichloroethene (TCE). These toxic compounds are primarily used in dry cleaning operations and degreasing of metal components. Complicating the situation are natural biotic and abiotic processes that transform these solvents to intermediate substances, such as toxic dichloroethenes, and cancer-causing agents, such as vinyl chloride.

But in a step toward engineering better bioremediation strategies, Georgia Tech researchers have isolated a naturally occurring bacterium, designated Dehalococcoides strain BAV1, in a pure culture without other microbial species present in the sample. Though some progress was made in the past decade in understanding the bacteria involved in partial degradation of PCE and TCE, this study represents a significant advance, researchers said.

"Isolating this bacterium will allow us to study the organism and the dechlorination process in
'"/>

Contact: Jane Sanders
jane.sanders@edi.gatech.edu
404-894-2214
Georgia Institute of Technology Research News
2-Jul-2003


Page: 1 2 3 4 5

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
3. Novel approaches to current cellular therapies continue progress toward disease prevention
4. Novel therapies show promise against myeloid leukemia
5. Novel sensors help clear the air
6. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
7. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
8. Novel therapeutic target identified in fight against Rheumatoid Arthritis
9. Novel flu vaccine shows promise in mice
10. Novel gene therapy on the horizon, says Brenner Childrens Hospital pediatrician
11. Novel method identifies hidden genes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Novel bacterium detoxifies chlorinated pollutants

(Date:5/20/2013)... 2013) University of Minnesota Medical School researchers from ... with the University,s Brain Tumor Program, have developed a ... (MPNST) that allow them to discover new genes and ... research was published this week in the journal ... method, researchers in the lab of David Largaespada, Ph.D., ...
(Date:5/20/2013)... planning grant will help establish the Center for Advanced ... University of Illinois at Urbana-Champaign and Worcester Polytechnic Institute ... to research in drying moist, porous materials such as ... chemical products; textiles; and biopharmaceuticals," said Hao Feng, a ... nutrition and the Illinois site director. , According to ...
(Date:5/19/2013)... study reports that white men and women of European ... valgus) and lesser toe deformities, including hammer or claw ... estimate the heritability of foot disorders in humansappear in ... by Wiley on behalf of the American College of ... many as 60% of older adults have foot disorders ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2NSF approves planning grant for Center for Advanced Research in Drying 2Blame your parents for bunion woes 2
(Date:5/21/2013)... Vital Imaging ™ has teamed ... San Diego for a joint study which aims to ... Resonance Imaging) with that of a supine Dynawell MRI ... of improved healthcare by combining cutting edge technology with ... valuable tool for evaluating pathological changes in the spine, ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Clinovo's ... an 8-week training program starting on June 11th, 2013. ... clinical trial professionals reach the next step in their ... Offices in Palo Alto, and streamed online. , Taught ... award-winning papers, Clinovo's new “CDISC Standards: Theory and Application” ...
(Date:5/20/2013)... May 20, 2013 Today, at the American ... , James McGough , M.D., ... the Semel Institute for Neuroscience and Human Behavior and ... at the University of California Los Angeles (UCLA), and ... Adolescent Psychopharmacology and ADHD at UCLA, presented the results ...
(Date:5/20/2013)... ROCKVILLE , Md. and BALTIMORE ... Inc. (BHI), a regional private-public partnership focusing ... to early-stage funding in Central Maryland ... Aiyar, Ph.D., M.B.A., as the first Entrepreneur-in-Residence (EIR) ... (NIH) National Heart, Lung and Blood Institute ...
Breaking Biology Technology:Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3Clinovo Launches TechTrainings on CDISC Standards 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4
Cached News: